Edrissian G H, Shahabi S, Pishva E, Hajseyed-Javadi J, Khaleghian B, Ghorbani M, Emadi A M, Afshar A, Saghari H
Bull Soc Pathol Exot Filiales. 1986;79(2):217-21.
Six imported cases of chloroquine-resistant Falciparum malaria have been studied since October 1984. In five cases including two Iranian men, returned from India, two Afghan and one Bengalee immigrants came to Iran through Pakistan, recrudescence occurred following treatment with chloroquine. In these five cases resistance of P. falciparum to chloroquine was clinically (by the in vivo test) at R1 level in all patients. The resistance was also confirmed by the macro in vitro susceptibility test which was carried out in four of them. These five chloroquine-resistant cases were treated, one with Sulfadiazine-Pyrimethamine, three with Quinine-Sulfadiazine-Pyrimethamine and one with Sulfadoxine-Pyrimethamine (Fansidar) successfully. In the sixth case who was a Pakistani tourist the parasites showed resistance in the macro in vitro test, but apparently responded to chloroquine treatment in three days. It seems the resistance in this case was also at R1 level as other cases.
自1984年10月以来,对6例输入性耐氯喹恶性疟病例进行了研究。其中5例,包括2名从印度返回的伊朗男子、2名阿富汗人和1名通过巴基斯坦来到伊朗的孟加拉移民,在用氯喹治疗后出现复发。在这5例中,所有患者体内的恶性疟原虫对氯喹的耐药性临床(通过体内试验)处于R1水平。其中4例进行的宏观体外药敏试验也证实了耐药性。这5例耐氯喹病例,1例用磺胺嘧啶-乙胺嘧啶治疗,3例用奎宁-磺胺嘧啶-乙胺嘧啶治疗,1例用周效磺胺-乙胺嘧啶(Fansidar)治疗,均获成功。第6例是一名巴基斯坦游客,其寄生虫在宏观体外试验中显示耐药,但显然在三天内对氯喹治疗有反应。看来该病例的耐药性与其他病例一样也处于R1水平。